在完成干扰素治疗后未获得持续病毒学应答的慢性丙型肝炎患者肝脏中8-硝基鸟嘌呤的蓄积。 - Suppr

Suppr

超能文献

Accumulation of 8-nitroguanine in the liver of chronic hepatitis C patients without sustained virological response after completion of interferon therapy.

作者信息

Kaito Masahiko, Horiike Shinichiro, Tanaka Hideaki, Fujita Naoki, Adachi Yukihiko

出版信息

J Gastroenterol. 2006 Jul;41(7):713-4. doi: 10.1007/s00535-006-1832-z.

DOI:10.1007/s00535-006-1832-z

PMID:16933012

Abstract

摘要

相似文献

Accumulation of 8-nitroguanine in the liver of chronic hepatitis C patients without sustained virological response after completion of interferon therapy.在完成干扰素治疗后未获得持续病毒学应答的慢性丙型肝炎患者肝脏中8-硝基鸟嘌呤的蓄积。

J Gastroenterol. 2006 Jul;41(7):713-4. doi: 10.1007/s00535-006-1832-z.

Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response.聚乙二醇干扰素α-2b与利巴韦林联合治疗基因4型慢性丙型肝炎：治疗疗程和病毒动力学对持续病毒学应答的影响

Gut. 2005 Jun;54(6):858-66. doi: 10.1136/gut.2004.057182.

Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver.铁调素/铁转运蛋白表达水平与聚乙二醇干扰素联合利巴韦林治疗丙型肝炎病毒感染肝脏的疗效相关。

World J Gastroenterol. 2015 Mar 21;21(11):3291-9. doi: 10.3748/wjg.v21.i11.3291.

The importance of the definition of early virological response for predicting treatment efficacy for chronic hepatitis C.早期病毒学应答的定义对于预测慢性丙型肝炎治疗疗效的重要性。

Hepatology. 2011 Apr;53(4):1403; author reply 1403. doi: 10.1002/hep.24117.

Impact of liver steatosis on virological response in [corrected] Italian patients with chronic hepatitis C treated with peg-interferon alpha-2b plus ribavarin.肝脂肪变性对接受聚乙二醇干扰素α-2b加利巴韦林治疗的意大利慢性丙型肝炎患者病毒学应答的影响。 [校正后]

Aliment Pharmacol Ther. 2005 May 1;21(9):1173-8. doi: 10.1111/j.1365-2036.2005.02452.x.

Hepatitis B virus and hepatitis C virus co-infection: a therapeutic challenge.乙型肝炎病毒和丙型肝炎病毒合并感染：治疗挑战。

Clin Res Hepatol Gastroenterol. 2013 Feb;37(1):e16-20. doi: 10.1016/j.clinre.2012.08.001. Epub 2012 Sep 5.

Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy.对接受各种基于干扰素的抗病毒治疗并获得持续病毒学应答的慢性丙型肝炎患者的长期随访。

Aliment Pharmacol Ther. 2006 Feb 15;23(4):507-11. doi: 10.1111/j.1365-2036.2006.02785.x.

An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C.初治基因1型慢性丙型肝炎患者对聚乙二醇干扰素联合利巴韦林双重治疗反应的先验预测模型。

Dig Liver Dis. 2014 Sep;46(9):818-25. doi: 10.1016/j.dld.2014.05.015. Epub 2014 Jun 20.

[Predictive value of virological response on sustained virological response in hepatitis C patients].

Zhonghua Gan Zang Bing Za Zhi. 2009 Dec;17(12):944-6.

Accumulation of 8-nitroguanine in the liver of patients with chronic hepatitis C.慢性丙型肝炎患者肝脏中8-硝基鸟嘌呤的蓄积。

J Hepatol. 2005 Sep;43(3):403-10. doi: 10.1016/j.jhep.2005.03.026.

本文引用的文献

Accumulation of 8-nitroguanine in the liver of patients with chronic hepatitis C.慢性丙型肝炎患者肝脏中8-硝基鸟嘌呤的蓄积。

J Hepatol. 2005 Sep;43(3):403-10. doi: 10.1016/j.jhep.2005.03.026.

Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon.慢性丙型肝炎患者经干扰素治疗获得持续应答后发生肝细胞癌的危险因素

J Gastroenterol. 2005 Feb;40(2):148-56. doi: 10.1007/s00535-004-1519-2.

Interferon therapy for 2 years or longer reduces the incidence of hepatocarcinogenesis in patients with chronic hepatitis C viral infection.对慢性丙型肝炎病毒感染患者进行2年或更长时间的干扰素治疗可降低肝癌发生的几率。

Intervirology. 2004;47(6):355-61. doi: 10.1159/000080880.

Radical causes of cancer.癌症的根本原因。

Nat Rev Cancer. 2003 Apr;3(4):276-85. doi: 10.1038/nrc1046.

Inflammation and cancer.炎症与癌症。

Nature. 2002;420(6917):860-7. doi: 10.1038/nature01322.

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.干扰素治疗对慢性丙型肝炎患者肝细胞癌发生的影响：一项对1643例患者采用比例风险分析进行统计偏差校正的长期观察研究。

Hepatology. 1999 Apr;29(4):1124-30. doi: 10.1002/hep.510290439.

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group.慢性丙型肝炎患者肝细胞癌的危险因素及其干扰素治疗后的发病率。大阪肝病研究小组。

Hepatology. 1998 May;27(5):1394-402. doi: 10.1002/hep.510270529.

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.干扰素α对伴有肝硬化的慢性活动性丙型肝炎患者肝细胞癌发生率影响的随机试验

Lancet. 1995 Oct 21;346(8982):1051-5. doi: 10.1016/s0140-6736(95)91739-x.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验